共 699 条
- [1] Zhang P(1999)The use of arsenic trioxide (As J Biol Regul Homeost Agents 13 195-200
- [2] Agis H(1999)O Ann Hematol 78 329-332
- [3] Weltermann A(1997)) in the treatment of acute promyelocytic leukemia Blood 89 3354-3360
- [4] Mitterbauer G(1998)Successful treatment with arsenic trioxide of a patient with ATRA-resistant relapse of acute promyelocytic leukemia Am J Pathol 153 1775-1785
- [5] Thalhammer R(2000)Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients J Environ Pathol Toxicol Oncol 19 281-286
- [6] Edelhauser M(2000)Arsenic enhancement of skin neoplasia by chronic stimulation of growth factors J Environ Pathol Toxicol Oncol 19 129-138
- [7] Seewann HL(2000)Mechanisms of arsenic carcinogenicity: Genetic or epigenetic mechanisms? Environ Health Perspect 108 655-661
- [8] Valent P(2000)Predisposing factors in occupational lung cancer: Inorganic minerals and chromium Cancer Invest 18 174-182
- [9] Lechner K(1989)Risk of internal cancers from arsenic in drinking water Biol Trace Elem Res 21 421-429
- [10] Fonatsch C(1996)Arsenic in drinking water and bladder cancer Cancer Lett 98 227-231